ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

AHG // Akso Health Group ADS

FA <GO> NASDAQ RQD COCKPIT → CIK 0001702318 ↗
Consumer Discretionary • Business Services
$1.33 ▲ +0.03 (+2.31%)
MKT CAP: $1.14B • VOL: 33.1K
AHG // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
LINE ITEM (USD / %)
FY 2025
FILED 2026-03-31
FY 2024
FILED 2025-03-31
FY 2023
FILED 2024-03-31
Revenue (Total Sales) $13.8M $14.8M $2.4M
YoY Revenue Growth % -6.4% +512.1% —
Gross Profit -$11.3K -$281.5K —
Gross Margin % -0.1% -1.9% —
Research & Development (R&D) — — —
Operating Income (EBIT) -$20.7M -$166.3M -$8.6M
Operating Margin % -80.0% -80.0% -80.0%
Net Income (GAAP) -$18.7M -$135.0M -$9.5M
EBITDA (Normalized) -$20.7M -$166.2M —
Diluted EPS ($/sh) — — —
Operating Cash Flow (OCF) -$12.8M $1.2M $1.4M
Capital Expenditures (CapEx) $1.6K $154.5K —
Free Cash Flow (FCF) -$12.8M $1.0M $1.4M
FCF Margin % -80.0% 6.9% 56.0%
Return on Invested Capital (ROIC %) — — —
Cash & Short-Term Equivalents — — —
Total Debt (Short + Long Term) — — —
Total Stockholders' Equity — — —